Tag: HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).

HIV First-in-class Pipeline Sees High Levels of Innovation

The human immunodeficiency virus (HIV) pipeline is robust, with 450 products in active development that display a high degree of novelty and diversity. Promisingly, there are 87 first-in-class product...

FDA Sent Response Letter to ViiV Healthcare on Cabotegravir and Rilpivirine Use

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, received a complete response letter (CRL) from the US Food and Drug Adm...

MSD’s HIV-1 Treatment Approved for NHS Use in England

MSD’s new HIV-1 treatment has been approved for use on the NHS. MSD has announced that its new treatment for HIV-1 infection – doravirine – has been recommended for NHS use in England. The decision me...

WHO Made New Recommendations on Expansion of HIV Treatment Coverage

The World Health Organization (WHO) has issued new recommendations to help countries reach 8.1 million people living with HIV who are yet to be diagnosed, and who are therefore unable to obtain li...

Abbott Scientists Identified New Subtype of Human Immunodeficiency Virus

Abbott announced that a team of its scientists identified a new subtype of the human immunodeficiency virus (HIV), called HIV-1 Group M, subtype L. The findings, published in the Journal of Acquired I...

Gilead Sciences Announced Positive Results of Biktarvy® Clinical Studies

clinical-trials
Gilead Sciences, Inc. announced findings from two randomized, double-blind, active-controlled Phase 3 studies (Study 1489 and Study 1490) evaluating the safety and efficacy of Biktarvy® (bictegravir 5...

FDA Approved Test for HIV Type-1 Detection

hiv
The U.S. Food and Drug Administration authorized marketing of a test to detect human immunodeficiency virus (HIV) Type-1 drug resistance mutations using next generation sequencing (NGS) technology. Th...

Russian and Chinese Genetics Use Genome Editing to Create New HIV Treatment

Genetics from China and Russia are working together to create a new HIV treatment using genome editing. This was told by the head of the genomic engineering laboratory of the Moscow Institute of Physi...

GSK Proposed to Reduce Tivikai Price

gsk
The British drug manufacturer GSK expressed the Russian Ministry of Health its proposal to reduce the price of its drug for the treatment of HIV dolutegravir (Tivikai) by 27%, Kommersant reports citin...

Johnson & Johnson Dedicated $500m to Eliminate HIV and Tuberculosis by 2030

JohnsonJohnson
Johnson & Johnson announced that it has committed to ensuring more than $500 million is dedicated to world class research & development and delivery programs over the next four years to accele...

FDA Approved Gilead’s Descovy

The U.S. Food and Drug Administration approved Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxi...

Australia Considers Relaxing Rules on Self-Test IVDs to Improve Screening

hiv
TGA is collecting feedback on the regulation of self-test in vitro diagnostic (IVD) devices. Australia has allowed the sale of self-test IVDs for HIV since 2014 and is now assessing whether to relax t...

RADIAN Initiative to Address HIV Infections in Eastern Europe and Central Asia Launched by Gilead

Gilead Sciences, Inc. and the Elton John AIDS Foundation announced the launch of the ground-breaking RADIAN initiative at the Fast-Track Cities 2019 conference in London. RADIAN seeks to meaningfully ...

Russian Researchers to Develop AIDS Treatment

Researchers from South Ural State University and the N.D. Zelinsky Institute of Organic Chemistry, Russian Academy of Sciences are studying polysulphur-nitrogen heterocycles – organic compounds which ...

Janssen Expanded Pediatric HIV Program to Zimbabwe

Johnson & Johnson announced that its Janssen Pharmaceutical Companies has expanded the New Horizons Collaborative to Zimbabwe - a first-of-its-kind integrated approach to improve pediatric HIV car...

Janssen Announced Positive Top-Line Results from Study of Cabotegravir

hiv
The Janssen Pharmaceutical Companies of Johnson & Johnson have announced positive top-line results from the Phase 3 ATLAS-2M study of the investigational, long-acting two-drug injectable regimen o...